Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Biomarkers to Predict Cancer Therapy-related Cardiotoxicity — Stella

Home/Hematopoietic and Lymphatic System Neoplasm/Biomarkers to Predict Cancer Therapy-related Cardiotoxicity

View on ClinicalTrials.gov

Recruiting

Back to Hematopoietic and Lymphatic System Neoplasm trials

Biomarkers to Predict Cancer Therapy-related Cardiotoxicity

Trial locations(4 sites)

United States

Mayo Clinic in Arizona, Scottsdale, Arizona

Mayo Clinic in Florida, Jacksonville, Florida

Moffitt Cancer Center, Tampa, Florida

Mayo Clinic in Rochester, Rochester, Minnesota

Key details

Sponsor

Mayo Clinic

Collaborators

National Heart, Lung, and Blood Institute (NHLBI)

Enrollment target

~1,000 participants

Started

May 2019

Primary completion

December 2031

Age range

18 Years and older

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.